Entheon Biomedical Corp (ENBI.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
(Values in thousands)
| 11-2025 | 11-2024 | 11-2023 | 11-2022 | 11-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | N/A | N/A | 0 | 2 | 488 |
| Accounts receivable | -4 | 2 | 36 | -7 | 78 |
| Other Working Capital | 7 | -38 | -57 | 437 | 437 |
| Other Operating Activity | -317 | -320 | -339 | -2,386 | -6,618 |
| Operating Cash Flow | $-315 | $-356 | $-360 | $-1,955 | $-5,615 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -98 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 384 |
| Purchase Of Investment | N/A | N/A | N/A | 0 | -406 |
| Sale Of Investment | N/A | 0 | 4 | 634 | 21 |
| Other Investing Activity | 0 | 0 | 20 | -48 | 0 |
| Investing Cash Flow | $N/A | $0 | $24 | $586 | $-99 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 500 | N/A | N/A | 0 | 3,083 |
| Other Financing Activity | 0 | 148 | 0 | 0 | 1,893 |
| Financing Cash Flow | $500 | $148 | $0 | $0 | $4,976 |
| Beginning Cash Position | 136 | 345 | 680 | 2,049 | 2,787 |
| End Cash Position | 322 | 136 | 345 | 680 | 2,049 |
| Net Cash Flow | $185 | $-208 | $-336 | $-1,369 | $-738 |
| Free Cash Flow | |||||
| Operating Cash Flow | -315 | -356 | -360 | -1,955 | -5,615 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -98 |
| Free Cash Flow | -315 | -356 | -360 | -1,955 | -5,713 |